Results 161 to 170 of about 15,541,955 (379)

Crosslinking of transcription factor TFIIIA to ribosomal 5S RNA fromX.laevisbytrans-diamminedichloroplatinum (II)

, 1989
Florence Baudin, Pascale Romby, Paul J. Romaniuk, Bernard Ehresmann, Chantal Ehresmann   +4 more
openalex   +2 more sources

Specific interaction between a transcription factor and the upstream element of the adenovirus-2 major late promoter. [PDF]

, 1985
Neil G. Miyamoto, Vincent Moncollin, J.M. Egly, Pierre Chambon   +3 more
openalex   +1 more source

A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment

Cell, 2000
S. Szabo, Sean T. Kim, G. Costa, Xiankui Zhang, C. Fathman, L. Glimcher   +5 more
semanticscholar   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Analysis of the RNA structural elements involved in the binding of the transcription factor III A fromXenopus laevis

, 1986
Tomas Pieler, Ulrich Guddat, Shiao Li Oei, Volker A. Erdmann   +3 more
openalex   +2 more sources

Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor [PDF]

, 1989
Long‐Sheng Chang, Yanhong Shi, Thomas Shenk   +2 more
openalex   +1 more source

The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor

Cell, 1997
Michael S. Brown, J. Goldstein
semanticscholar   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

Molecular Oncology, EarlyView.
Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides, Sara Cristobal‐Vargas, Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz‐Krzeminska, Isabel Isidro, José Juan Pérez, Bruno Paiva, Noemi Puig, Miguel Alcoceba, María‐Victoria Mateos, Luis A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez   +13 more
wiley   +1 more source

Defining the binding site ofXenopustranscription factor IIIA on 5S RNA using truncated and chimeric 5S RNA molecules [PDF]

, 1987
Paul J. Romaniuk, Isable Leal de Stevenson, Hua Wong   +2 more
openalex   +1 more source